Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Fahed A Elian, Ubah Are, Sunita Ghosh, Paulo Nuin, Tim Footz, Todd P W McMullen, David N Brindley & Michael A Walter. (2021) FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival. Breast Cancer: Targets and Therapy 13, pages 171-188.
Read now
Read now
Morenci Manning, Yuanyuan Jiang, Rui Wang, Lanxin Liu, Shomita Rode, Madison Bonahoom, Seongho Kim & Zeng-Quan Yang. (2020) Pan-cancer analysis of RNA methyltransferases identifies FTSJ3 as a potential regulator of breast cancer progression. RNA Biology 17:4, pages 474-486.
Read now
Read now
Shabnam Jeibouei, Mohammad Esmael Akbari, Alireza Kalbasi, Amir Reza Aref, Mohammad Ajoudanian, Alireza Rezvani & Hakimeh Zali. (2019) Personalized medicine in breast cancer: pharmacogenomics approaches. Pharmacogenomics and Personalized Medicine 12, pages 59-73.
Read now
Read now
David P Boyle, Clare M McCourt, Kyle B Matchett & Manuel Salto-Tellez. (2013) Molecular and clinicopathological markers of prognosis in breast cancer. Expert Review of Molecular Diagnostics 13:5, pages 481-498.
Read now
Read now
Articles from other publishers (46)
Karl Gardner, Rutwik Joshi, Md Nayeem Hasan Kashem, Thanh Quang Pham, Qiugang Lu & Wei Li. (2023) Label free identification of different cancer cells using deep learning-based image analysis. APL Machine Learning 1:2.
Crossref
Crossref
Pâmella Aparecida Ferreira Fagotti, Matheus Iago Oliveira Colleto, Mariane Okamoto Ferreira, Vitor Teixeira Maito, Bruno Vinicius Campestrini, Thalita Basso Scandolara, Janoário Athanázio de Souza, Daniel Rech, Janaína Carla da Silva, Fernanda Mara Alves, Vanessa Jacob Victorino, Danielle Venturini & Carolina Panis. (2023) Impact of body mass index on the circulating levels of nitric oxide metabolites in clinicopathological features from women with breast cancer. Precision Medical Sciences.
Crossref
Crossref
Carlotta Mazzitelli, Donatella Santini, Angelo Gianluca Corradini, Claudio Zamagni, Davide Trerè, Lorenzo Montanaro & Mario Taffurelli. (2023) Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going. Diagnostics 13:7, pages 1241.
Crossref
Crossref
Michael Gnant, Christian F. Singer, Gabriel Rinnerthaler, Georg Pfeiler, Daniel Egle, Marija Balic & Rupert Bartsch. (2023) Position paper on CDK4/6 inhibitors in early breast cancer. memo - Magazine of European Medical Oncology.
Crossref
Crossref
Jingtong Zhai, Jiashu Han, Cong Li, Fengzhu Guo, Fei Ma & Binghe Xu. (2022) High SURF4 expression is associated with poor prognosis of breast cancer. Aging 14:22, pages 9317-9337.
Crossref
Crossref
Aitor Rodriguez-Casanova, Nicolas Costa-Fraga, Clara Castro-Carballeira, Miriam González-Conde, Carmen Abuin, Aida Bao-Caamano, Tomás García-Caballero, Elena Brozos-Vazquez, Carmela Rodriguez-López, Victor Cebey, Patricia Palacios, Juan F. Cueva, Rafael López-López, Clotilde Costa & Angel Díaz-Lagares. (2022) A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Qiuyu Liu, Wanda van der Stel, Vera E. van der Noord, Hanneke Leegwater, Bircan Coban, Kim Elbertse, Joannes T. M. Pruijs, Olivier J. M. Béquignon, Gerard van Westen, Sylvia E. Le Dévédec & Erik H. J. Danen. (2022) Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells. International Journal of Molecular Sciences 23:17, pages 10119.
Crossref
Crossref
Taesung Jeon, Hayeon Kim, Aeree Kim & Chungyeul Kim. (2022) A systematic study on phenotypical characteristics of invasive breast carcinoma and surrounding ductal carcinoma in situ in multifocal breast cancers. Human Pathology 127, pages 12-20.
Crossref
Crossref
Sridevi Addanki, Salyna Meas, Vanessa Nicole Sarli, Balraj Singh & Anthony Lucci. (2022) Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers. International Journal of Molecular Sciences 23:14, pages 7843.
Crossref
Crossref
Helga Bergholtz, Tonje Lien, Frode Lingaas & Therese Sørlie. (2022) Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors. Journal of Mammary Gland Biology and Neoplasia 27:2, pages 171-183.
Crossref
Crossref
Candelario Hernández-Gómez, Enrique Hernández-Lemus & Jesús Espinal-Enríquez. (2022) The Role of Copy Number Variants in Gene Co-Expression Patterns for Luminal B Breast Tumors. Frontiers in Genetics 13.
Crossref
Crossref
Meredith M. Ogle, Rolando TrevinoJr.Jr., Joseph Schell, Mahboubeh Varmazyad, Nobuo Horikoshi & David Gius. (2022) Manganese Superoxide Dismutase Acetylation and Regulation of Protein Structure in Breast Cancer Biology and Therapy. Antioxidants 11:4, pages 635.
Crossref
Crossref
Michael Abiodun Adeyanju. (2022) MOLECULAR SUBTYPES OF BREAST CANCER. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 15-16.
Crossref
Crossref
Nam Nhut Phan, Chi-Cheng Huang, Ling-Ming Tseng & Eric Y. Chuang. (2021) Predicting Breast Cancer Gene Expression Signature by Applying Deep Convolutional Neural Networks From Unannotated Pathological Images. Frontiers in Oncology 11.
Crossref
Crossref
Alba Orea-Soufi, Sonia Castillo-Lluva, Nélida Salvador-Tormo, Paola Martín-Cabrera, Silvia Recuero, Estíbaliz Gabicagogeascoa, Manuel Moreno-Valladares, Marina Mendiburu-Eliçabe, Adrián Blanco-Gómez, José Miguel Ramos-Pittol, Elena García-Taboada, Alberto Ocaña, Francisco J. Cimas, Ander Matheu, Isabel Álvarez-López, Guillermo Velasco & Mar Lorente. (2021) The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer. Cancers 13:21, pages 5307.
Crossref
Crossref
Ayad Ahmad Mohammed. (2021) Prognostic parameter differences in breast cancer patients between luminal A and luminal B types after application of the new classification according to Ki67 score. International Journal of Surgery Open 34, pages 100357.
Crossref
Crossref
Mai Ahmed Shafei, Arwa Flemban, Carl Daly, Paul Kendrick, Paul White, Sarah Dean, David Qualtrough & Myra E. Conway. (2020) Differential expression of the BCAT isoforms between breast cancer subtypes. Breast Cancer 28:3, pages 592-607.
Crossref
Crossref
Signe Korsgaard Skriver, Maj-Britt Jensen, Ann Soegaard Knoop, Bent Ejlertsen & Anne-Vibeke Laenkholm. (2020) Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial. Breast Cancer Research 22:1.
Crossref
Crossref
Zhen Li, Wei Zou, Ji Zhang, Yunjiao Zhang, Qi Xu, Siyuan Li & Ceshi Chen. (2020) Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer. Frontiers in Pharmacology 11.
Crossref
Crossref
Anniina Jääskeläinen, Nelli Roininen, Peeter Karihtala & Arja Jukkola. (2020) High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study. Frontiers in Oncology 10.
Crossref
Crossref
Haoran Li, Alexander Aue, Debashis Paul, Jie Peng & Pei Wang. (2020) An adaptable generalization of Hotelling’s $T^{2}$ test in high dimension. The Annals of Statistics 48:3.
Crossref
Crossref
Begoña Alday-Parejo, François Richard, Janine Wörthmüller, Tilman Rau, José A. Galván, Christine Desmedt, Albert Santamaria-Martinez & Curzio Rüegg. (2020) MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer. Cancers 12:1, pages 223.
Crossref
Crossref
Julian Puppe, Tabea Seifert, Christian Eichler, Henryk Pilch, Peter Mallmann & Wolfram Malter. (2020) Genomic Signatures in Luminal Breast Cancer. Breast Care 15:4, pages 355-365.
Crossref
Crossref
Irene De Santo, Amelia McCartney, Ilenia Migliaccio, Angelo Di Leo & Luca Malorni. (2019) The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy. Cancers 11:12, pages 1894.
Crossref
Crossref
Constantin N. Baxevanis, Michael Sofopoulos, Sotirios P. Fortis & Sonia A. Perez. (2019) The role of immune infiltrates as prognostic biomarkers in patients with breast cancer. Cancer Immunology, Immunotherapy 68:10, pages 1671-1680.
Crossref
Crossref
Lutfi Alfarsi, Simon Johnston, Dong-Xu Liu, Emad Rakha & Andrew R Green. (2018) Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer. Histopathology 73:4, pages 545-558.
Crossref
Crossref
Vida Pourteimoor, Mahdi Paryan & Samira Mohammadi‐Yeganeh. (2018) microRNA as a systemic intervention in the specific breast cancer subtypes with C‐MYC impacts; introducing subtype‐based appraisal tool. Journal of Cellular Physiology 233:8, pages 5655-5669.
Crossref
Crossref
Jorge A. Belgodere, Connor T. King, Jacob B. Bursavich, Matthew E. Burow, Elizabeth C. Martin & Jangwook P. Jung. (2018) Engineering Breast Cancer Microenvironments and 3D Bioprinting. Frontiers in Bioengineering and Biotechnology 6.
Crossref
Crossref
Chengyu Liu, Rainer Lehtonen & Sampsa Hautaniemi. (2018) PerPAS: Topology-Based Single Sample Pathway Analysis Method. IEEE/ACM Transactions on Computational Biology and Bioinformatics 15:3, pages 1022-1027.
Crossref
Crossref
S. L. Villegas, S. Darb-Esfahani, G. von Minckwitz, J. Huober, K. Weber, F. Marmé, J. Furlanetto, C. Schem, B. M. Pfitzner, B. Lederer, K. Engels, S. Kümmel, V. Müller, K. Mehta, C. Denkert & S. Loibl. (2017) Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment 168:1, pages 179-187.
Crossref
Crossref
Farah J. Nassar, Rabih Talhouk, Nathalie K. Zgheib, Arafat Tfayli, Maya El Sabban, Nagi S. El Saghir, Fouad Boulos, Mark N. Jabbour, Claude Chalala, Rose-Mary Boustany, Humam Kadara, Zhou Zhang, Yinan Zheng, Brian Joyce, Lifang Hou, Ali Bazarbachi, George Calin & Rihab Nasr. (2017) microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis. Scientific Reports 7:1.
Crossref
Crossref
Qi Mao, Li Wang, Ivor W. Tsang & Yijun Sun. (2017) Principal Graph and Structure Learning Based on Reversed Graph Embedding. IEEE Transactions on Pattern Analysis and Machine Intelligence 39:11, pages 2227-2241.
Crossref
Crossref
Cristóbal Fresno, Germán Alexis González, Gabriela Alejandra Merino, Ana Georgina Flesia, Osvaldo Luis Podhajcer, Andrea Sabina Llera & Elmer Andrés Fernández. (2017) A novel non-parametric method for uncertainty evaluation of correlation-based molecular signatures: its application on PAM50 algorithm. Bioinformatics 33:5, pages 693-700.
Crossref
Crossref
Irida Kastrati. 2017. Resistance to Targeted Therapies in Breast Cancer. Resistance to Targeted Therapies in Breast Cancer
89
101
.
Sarah M. Bernhardt, Pallave Dasari, David Walsh, Amanda R. Townsend, Timothy J. Price & Wendy V. Ingman. (2016) Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women. Frontiers in Oncology 6.
Crossref
Crossref
Adrienne Conger, Elizabeth Martin, Thomas Yan, Lyndsay Rhodes, Van Hoang, Jacqueline La, Muralidharan Anbalagan, Hope Burks, Brian Rowan, Kenneth Nephew, Bridgette Collins-Burow & Matthew Burow. (2016) Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation. Non-Coding RNA 2:3, pages 8.
Crossref
Crossref
James R. Bradford, Mark Wappett, Garry Beran, Armelle Logie, Oona Delpuech, Henry Brown, Joanna Boros, Nicola J. Camp, Robert McEwen, Anne Marie Mazzola, Celina D’Cruz & Simon T. Barry. (2016) Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers. Oncotarget 7:15, pages 20773-20787.
Crossref
Crossref
Yuanyuan Jiang, Lanxin Liu, Wenqi Shan & Zeng-Quan Yang. (2016) An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer. Molecular Oncology 10:2, pages 292-302.
Crossref
Crossref
Rafael Bispo Paschoalini, Rozany Mucha Dufloth, Francisco Alves Moraes Neto & Fernando C. Schmitt. (2016) Cytological Criteria for Predicting the Luminal Phenotype of Breast Carcinoma. Acta Cytologica 60:5, pages 406-412.
Crossref
Crossref
Minna K. Lee, Leo A. Varzi, Debra U. Chung, Minh-an Cao, Jeffrey Gornbein, Sophia K. Apple & Helena R. Chang. (2015) The Effect of Young Age in Hormone Receptor Positive Breast Cancer. BioMed Research International 2015, pages 1-6.
Crossref
Crossref
Aleksandra B Adomas, Sara A Grimm, Christine Malone, Motoki Takaku, Jennifer K Sims & Paul A Wade. (2014) Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover. BMC Cancer 14:1.
Crossref
Crossref
Nabila S. Rattani & Theresa Swift-Scanlan. (2014) Deconstructing Breast Cancer Heterogeneity: Clinical Implications for Women With Basal-Like Tumors. Oncology Nursing Forum 41:6, pages 639-646.
Crossref
Crossref
Konstantinos G. Sidiropoulos, Nicole M.A. White, Anna Bui, Qiang Ding, Peter Boulos, Georgios Pampalakis, Heba Khella, Joseph N. Samuel, Georgia Sotiropoulou & George M. Yousef. (2014) Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer. Oncoscience 1:11, pages 709-724.
Crossref
Crossref
Enida Bufi, Paolo Belli, Marialuisa Di Matteo, Daniela Terribile, Gianluca Franceschini, Luigia Nardone, Gianluigi Petrone & Lorenzo Bonomo. (2014) Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment. European Journal of Radiology 83:9, pages 1631-1638.
Crossref
Crossref
Ozlem Yersal. (2014) Biological subtypes of breast cancer: Prognostic and therapeutic implications. World Journal of Clinical Oncology 5:3, pages 412.
Crossref
Crossref
Meng Zhao. (2014) Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer. World Journal of Clinical Oncology 5:3, pages 248.
Crossref
Crossref